drug protocol number

MK-8835-059-00

drug sponsor

MSD

drug study

Ertugliflozin

drug trial site

King Salman Hospital (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Fahad Medical City (Riyadh)

drug status

Ongoing

drug phase